These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 3496789)
1. The role of dialysate in the stimulation of interleukin-1 production during clinical hemodialysis. Port FK; VanDeKerkhove KM; Kunkel SL; Kluger MJ Am J Kidney Dis; 1987 Aug; 10(2):118-22. PubMed ID: 3496789 [TBL] [Abstract][Full Text] [Related]
2. Easy production of sterile, pyrogen-free dialysate. Erley CM; von Herrath D; Hartenstein-Koch K; Kutschera D; Amir-Moazami B; Schaefer K ASAIO Trans; 1988; 34(3):205-7. PubMed ID: 3196509 [TBL] [Abstract][Full Text] [Related]
3. Cytokine production during in vitro hemodialysis with new and formaldehyde- or renalin-reprocessed cellulose dialyzers. Pereira BJ; Snodgrass B; Barber G; Perella C; Chopra S; King AJ J Am Soc Nephrol; 1995 Oct; 6(4):1304-8. PubMed ID: 8589302 [TBL] [Abstract][Full Text] [Related]
4. Detection of endotoxin-like interleukin-1-inducing activity during in vitro dialysis. Lonnemann G; Bingel M; Floege J; Koch KM; Shaldon S; Dinarello CA Kidney Int; 1988 Jan; 33(1):29-35. PubMed ID: 3280853 [TBL] [Abstract][Full Text] [Related]
5. Pyrogen retention by the Asahi APS-650 polysulfone dialyzer during in vitro dialysis with whole human donor blood. Linnenweber S; Lonnemann G ASAIO J; 2000; 46(4):444-7. PubMed ID: 10926143 [TBL] [Abstract][Full Text] [Related]
6. Effects of ultrapure and non-sterile dialysate on the inflammatory response during in vitro hemodialysis. Tielemans C; Husson C; Schurmans T; Gastaldello K; Madhoun P; Delville JP; Marchant A; Goldman M; Vanherweghem JL Kidney Int; 1996 Jan; 49(1):236-43. PubMed ID: 8770974 [TBL] [Abstract][Full Text] [Related]
7. Transmembrane passage of cytokine-inducing bacterial products across new and reprocessed polysulfone dialyzers. Sundaram S; Barrett TW; Meyer KB; Perrella C; Neto MC; King AJ; Pereira BJ J Am Soc Nephrol; 1996 Oct; 7(10):2183-91. PubMed ID: 8915979 [TBL] [Abstract][Full Text] [Related]
8. Transfer of cytokine-inducing bacterial products across hemodialyzer membranes in the presence of plasma or whole blood. Pereira BJ; Sundaram S; Barrett TW; Butt NK; Porat R; King AJ; Dinarello CA Clin Nephrol; 1996 Dec; 46(6):394-401. PubMed ID: 8982556 [TBL] [Abstract][Full Text] [Related]
11. Pyrogen retention by highly permeable synthetic membranes during in vitro dialysis. Lonnemann G; Sereni L; Lemke HD; Tetta C Artif Organs; 2001 Dec; 25(12):951-60. PubMed ID: 11843762 [TBL] [Abstract][Full Text] [Related]
12. In vivo studies of dialysis-related endotoxemia and bacteremia. Bernick JJ; Port FK; Favero MS Nephron; 1981; 27(6):307-12. PubMed ID: 7266719 [TBL] [Abstract][Full Text] [Related]
13. Plasma interleukin-1 activity in humans undergoing hemodialysis with regenerated cellulosic membranes. Lonnemann G; Bingel M; Koch KM; Shaldon S; Dinarello CA Lymphokine Res; 1987; 6(2):63-70. PubMed ID: 3495707 [TBL] [Abstract][Full Text] [Related]
14. Permeability of cellulosic and non-cellulosic membranes to endotoxin subunits and cytokine production during in-vitro haemodialysis. Ureña P; Herbelin A; Zingraff J; Lair M; Man NK; Descamps-Latscha B; Drüeke T Nephrol Dial Transplant; 1992; 7(1):16-28. PubMed ID: 1316577 [TBL] [Abstract][Full Text] [Related]
15. New polyether sulfone dialyzers attenuate passage of cytokine-inducing substances from pseudomonas aeruginosa contaminated dialysate. Jaber BL; Gonski JA; Cendoroglo M; Balakrishnan VS; Razeghi P; Dinarello CA; Pereira BJ Blood Purif; 1998; 16(4):210-9. PubMed ID: 9736790 [TBL] [Abstract][Full Text] [Related]
16. Tumor necrosis factor-alpha during continuous high-flux hemodialysis in sepsis with acute renal failure. Lonnemann G; Bechstein M; Linnenweber S; Burg M; Koch KM Kidney Int Suppl; 1999 Nov; (72):S84-7. PubMed ID: 10560813 [TBL] [Abstract][Full Text] [Related]
17. The effect of ultrafiltered dialysate on the cellular content of interleukin-1 receptor antagonist in patients on chronic hemodialysis. Schindler R; Lonnemann G; Schäffer J; Shaldon S; Koch KM; Krautzig S Nephron; 1994; 68(2):229-33. PubMed ID: 7830861 [TBL] [Abstract][Full Text] [Related]
18. Ultrafiltration and endotoxin removal from dialysis fluids. Di Felice A; Cappelli G; Facchini F; Tetta C; Cornia F; Aimo G; Lusvarghi E Kidney Int Suppl; 1993 Jun; 41():S201-4. PubMed ID: 8320921 [TBL] [Abstract][Full Text] [Related]
19. [Dialysate and biocompatibility in hemodialysis]. Berland Y Nephrologie; 1998; 19(6):329-34. PubMed ID: 9836194 [TBL] [Abstract][Full Text] [Related]
20. Tumor necrosis factor (cachectin) is an endogenous pyrogen and induces production of interleukin 1. Dinarello CA; Cannon JG; Wolff SM; Bernheim HA; Beutler B; Cerami A; Figari IS; Palladino MA; O'Connor JV J Exp Med; 1986 Jun; 163(6):1433-50. PubMed ID: 3486936 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]